Signaturefd, LLC Vertex Pharmaceuticals Inc Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Signaturefd, LLC holds 5,149 shares of VRTX stock, worth $2.1 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,149

Previous 5,094 1.08%

Holding current value

$2.1 Million

Previous $2.39 Million 0.29%

% of portfolio

0.05%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$460.0 - $505.78 $25,300 - $27,817	55 Added 1.08%	5,149 $2.39 Million
Q2 2024 Jul 29, 2024	SELL	$392.81 - $485.53 $74,633 - $92,250	-190 Reduced 3.6%	5,094 $2.39 Million
Q1 2024 May 03, 2024	BUY	$407.69 - $446.08 $158,183 - $173,079	388 Added 7.92%	5,284 $2.21 Million
Q4 2023 Jan 31, 2024	BUY	$343.0 - $410.68 $153,664 - $183,984	448 Added 10.07%	4,896 $1.99 Million
Q3 2023 Nov 03, 2023	BUY	$338.18 - $362.46 $104,159 - $111,637	308 Added 7.44%	4,448 $1.55 Million
Q2 2023 Aug 01, 2023	BUY	$314.42 - $351.91 $121,366 - $135,837	386 Added 10.28%	4,140 $1.46 Million
Q1 2023 Apr 28, 2023	BUY	$283.23 - $323.1 $77,038 - $87,883	272 Added 7.81%	3,754 $1.18 Million
Q4 2022 Jan 27, 2023	BUY	$285.76 - $321.48 $35,720 - $40,185	125 Added 3.72%	3,482 $1.01 Million
Q3 2022 Nov 08, 2022	BUY	$273.83 - $305.53 $106,246 - $118,545	388 Added 13.07%	3,357 $972,000
Q2 2022 Aug 10, 2022	BUY	$234.96 - $292.55 $78,006 - $97,126	332 Added 12.59%	2,969 $837,000
Q1 2022 May 02, 2022	BUY	$221.42 - $260.97 $73,068 - $86,120	330 Added 14.3%	2,637 $688,000
Q4 2021 Jan 25, 2022	BUY	$177.01 - $223.45 $111,693 - $140,996	631 Added 37.65%	2,307 $507,000
Q3 2021 Oct 28, 2021	SELL	$181.39 - $202.99 $296,754 - $332,091	-1,636 Reduced 49.4%	1,676 $304,000
Q2 2021 Jul 26, 2021	BUY	$187.49 - $221.1 $562 - $663	3 Added 0.09%	3,312 $668,000
Q1 2021 Apr 30, 2021	BUY	$207.02 - $241.31 $54,653 - $63,705	264 Added 8.67%	3,309 $711,000
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $216,118 - $288,237	1,044 Added 52.17%	3,045 $720,000
Q3 2020 Nov 03, 2020	SELL	$255.65 - $303.1 $9,203 - $10,911	-36 Reduced 1.77%	2,001 $545,000
Q2 2020 Jul 30, 2020	BUY	$225.48 - $295.8 $89,741 - $117,728	398 Added 24.28%	2,037 $591,000
Q1 2020 Apr 23, 2020	BUY	$199.77 - $247.81 $53,937 - $66,908	270 Added 19.72%	1,639 $390,000
Q4 2019 Feb 05, 2020	BUY	$166.71 - $223.91 $23,839 - $32,019	143 Added 11.66%	1,369 $300,000
Q3 2019 Oct 16, 2019	BUY	$166.23 - $187.09 $34,908 - $39,288	210 Added 20.67%	1,226 $208,000
Q2 2019 Jul 31, 2019	BUY	$164.61 - $190.37 $11,851 - $13,706	72 Added 7.63%	1,016 $186,000
Q1 2019 May 09, 2019	SELL	$163.73 - $194.7 $1,309 - $1,557	-8 Reduced 0.84%	944 $174,000
Q4 2018 Feb 13, 2019	BUY	$151.91 - $192.21 $29,014 - $36,712	191 Added 25.1%	952 $158,000
Q3 2018 Nov 15, 2018	BUY	$167.73 - $192.74 $3,690 - $4,240	22 Added 2.98%	761 $147,000
Q2 2018 Aug 14, 2018	SELL	$145.72 - $169.96 $9,034 - $10,537	-62 Reduced 7.74%	739 $126,000
Q1 2018 May 08, 2018	BUY	$151.6 - $177.13 $121,431 - $141,881	801 New	801 $131,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $105B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account